S&P 500 recovered most of the intraday downside, and in spite of value driving the upswing, there is something odd about it. Tech barely moved higher during the day, and the heavyweights continue being beaten similarly to biotech compared to the rest of healthcare. The key oddity though was in the risk-off posture in bonds, […]
Jump To The Original Source